Gesine Meyer-Rath to Tenofovir
This is a "connection" page, showing publications Gesine Meyer-Rath has written about Tenofovir.
Connection Strength
0,217
-
Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis. Lancet HIV. 2022 12; 9(12):e857-e867.
Score: 0,191
-
Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC Infect Dis. 2014 Jan 09; 14:14.
Score: 0,026